DCLK1 and cholangiocarcinoma: DCLK1 directly marks cancer stem cells in colon cancer [55], pancreatic cancer [56], and cholangiocarcinoma [57], promotes CSC-like properties and drives cancer initiation, progression, and metastatic spread [10].